(MJ) Alternative Harvest - Overview
Etf: Cannabis, Cultivation, Production, Marketing, Distribution, Hemp
Dividends
| Dividend Yield | 1.98% |
| Yield on Cost 5y | 0.24% |
| Yield CAGR 5y | 28.91% |
| Payout Consistency | 67.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 61.0% |
| Relative Tail Risk | -13.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.33 |
| Alpha | -14.74 |
| Character TTM | |
|---|---|
| Beta | 0.908 |
| Beta Downside | 1.204 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.73% |
| CAGR/Max DD | -0.22 |
Description: MJ Alternative Harvest December 31, 2025
The Amplify Alternative Harvest ETF (NYSE ARCA: MJ) is a non-diversified fund that commits at least 80% of its net assets to securities tracking its underlying index, which targets global and U.S. companies involved in the cultivation, production, marketing, or distribution of cannabis and industrial hemp, as well as firms that handle cannabis-derived products for medical or recreational use.
Key sector metrics that can affect MJ’s performance include: (1) the global legal cannabis market, projected by Grand View Research to reach roughly $90 billion by 2027, growing at a compound annual growth rate (CAGR) of ~18%; (2) U.S. federal-state regulatory divergence, where state-level legalization drives revenue spikes but federal prohibition introduces supply-chain and banking constraints; and (3) the “hemp-derived CBD” segment, which saw a 2023 revenue increase of about 30% YoY, reflecting expanding consumer demand for wellness products. Investors should monitor quarterly earnings of top holdings (e.g., Canopy Growth, Curaleaf) and policy developments such as the SAFE Banking Act, as these are primary drivers of fund volatility.
For a deeper, data-driven dive into MJ’s risk-adjusted returns and exposure breakdown, you may find ValueRay’s analytical platform useful.
What is the price of MJ shares?
Over the past week, the price has changed by +1.80%, over one month by -10.31%, over three months by -6.31% and over the past year by -0.16%.
Is MJ a buy, sell or hold?
What are the forecasts/targets for the MJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.3 | -8.3% |
MJ Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 250.7m USD (250.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 250.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 250.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.26% (E(250.7m)/V(250.7m) * Re(9.26%) + (debt-free company))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)